In the Asia-Pacific medical devices industry, there were 39 M&A deals announced in Q3 2024, worth a total value of $818.8m, according to GlobalData’s Deals Database. The $595.5m minority acquisition of Agilus Diagnostics by Fortis Healthcare and Resurgence PE Investments was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, M&A activity in Asia-Pacific increased by 70% in Q3 2024 compared with the previous quarter’s total of $480.4m and rose by 247% as compared to Q3 2023. Related deal volume increased by 63% in Q3 2024 versus the previous quarter and was 63% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in Asia-Pacific in 9M 2024 were Jefferies Financial Group; Barrenjoey Capital Partners; Global Fund with 2, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Asia-Pacific in 9M 2024 were Buddle Findlay; Cleary Gottlieb Steen & Hamilton; Darryl, Edward & Co with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.